The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
893996
WO Application Number:
EP9701548
Type:
European Patent Granted for NL
Status:
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Opposition legitimate; revoke patent (art. 102 EOV)
Application number:
979154416
WO Publication Number:
WO97035575
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:
EP893996;
Dates
Filing date:
26/03/1997
Grant date:
18/09/2002
EP Publication Date:
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
18/09/2002
EP B1 Publication Date:
18/09/2002
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
13/12/2002
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
25/03/2017
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
06/08/2008
Applicant/holder
From:
18/09/2002
Name:
Novartis AG
Address:
4056 Basel, Switzerland (CH)
Domicile Holder
1
Name:
Dr. R. Jorritsma c.s.
From:
02/02/2004
Address:
N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)
To:
2
Name:
Dr. R. Jorritsma c.s.
From:
27/09/2002
Address:
N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)